At Novotech, we are dedicated to fostering a diverse, equitable and inclusive workplace where all employees, regardless of gender, feel valued, respected and supported.
A key focus of our diversity and inclusion efforts is achieving greater gender balance across all levels of our organisation. To that end, we have set clear goals and targets aimed at maintaining gender parity in leadership roles, ensuring equal access to career development opportunities, and eliminating any existing pay gaps between men and women.
"At Novotech, we firmly believe in diversity, inclusion and gender equality," said Dr. John Moller, CEO of Novotech Holdings. "Our certification by WGEA as a leading Employer of Choice for Gender Equality underscores our progress, but we have further work to do. I am fully committed to achieving equal pay, eliminating our gender pay gap worldwide, and maintaining zero tolerance for harassment and discrimination. We will continue expanding our diversity and inclusion efforts globally, as we know that equality strengthens our organisation, drives innovation and enhances our ability to serve customers."
On October 19, 2023, Novotech hosted a panel discussion titled "Tackling Gender Disparities in the Life Sciences" featuring both internal and external leaders. The event was moderated by our CEO Dr. John Moller, and reinforced our commitment to gender equality and highlighted the importance of achieving parity in an industry where women are underrepresented, especially in senior roles.
Our strategy emphasises leadership accountability, transparent compensation practices, work-life balance policies, zero tolerance for discrimination and harassment, regular data collection and reporting, and continuous evaluation and improvement of our gender equality initiatives.
We're proud to drive positive change as we create an approachable workplace where everyone's talents help us innovate, serve customers, and succeed. By embracing all our people, we can make great strides that benefit employees, clients, and communities.
Defining Gender Gaps
Introducing Gender Diversity from Entry Roles
Quality Processes
Reducing Gender Pay Gap
Tackling Gender Disparities
Media contact
Toyna Chin
About Novotech Novotech-CRO.com
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost & Sullivan 2024 Global Biotech CRO Award, 2024 Clinical Trials Arena Award for Excellence in Business Expansion, Marketing, and Innovation, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com